Suzy V Torti Selected Research

Apoferritins

1/2017	DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms.
1/2015	Cytoprotective Effect of Ferritin H in Renal Ischemia Reperfusion Injury.
1/2014	IRP2 regulates breast tumor growth.
8/2010	Ferritin H induction by histone deacetylase inhibitors.
10/2005	TIM-2 is expressed on B cells and in liver and kidney and is a receptor for H-ferritin endocytosis.
1/2003	Nrf2 mediates the induction of ferritin H in response to xenobiotics and cancer chemopreventive dithiolethiones.
1/2003	Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Suzy V Torti Research Topics

Disease

52	Neoplasms (Cancer) 12/2020 - 02/2002
13	Breast Neoplasms (Breast Cancer) 01/2018 - 08/2010
9	Neoplasm Metastasis (Metastasis) 01/2018 - 08/2010
5	Prostatic Neoplasms (Prostate Cancer) 10/2019 - 01/2009
5	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2014 - 01/2003
5	Iron Overload 12/2009 - 07/2002
4	Inflammation (Inflammations) 08/2010 - 11/2004
4	Iron Deficiencies 08/2010 - 01/2003
3	Ovarian Neoplasms (Ovarian Cancer) 10/2019 - 01/2018
3	Kidney Neoplasms (Kidney Cancer) 11/2010 - 01/2007
2	Disease Progression 10/2019 - 12/2009
2	Carcinogenesis 01/2018 - 01/2016
2	Anemia 01/2016 - 01/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2014 - 12/2009
2	Atherosclerosis 01/2014 - 12/2009
2	Chronic Disease (Chronic Diseases) 01/2014 - 01/2009
2	Hyperthermia 12/2013 - 04/2012
2	Renal Cell Carcinoma (Grawitz Tumor) 12/2010 - 02/2008
2	Pathologic Processes 08/2010 - 05/2009
1	Hemochromatosis (Bronze Diabetes) 01/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 05/2015
1	Ischemia 01/2015
1	Reperfusion Injury 01/2015
1	Acute Kidney Injury (Acute Renal Failure) 01/2015
1	Triple Negative Breast Neoplasms 01/2015
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2014
1	Hypoxia (Hypoxemia) 05/2013
1	Necrosis 04/2012
1	Lymphatic Metastasis 11/2011

Drug/Important Bio-Agent (IBA)

37	IronIBA 12/2020 - 07/2002
17	Proteins (Proteins, Gene)FDA Link 10/2019 - 01/2003
10	Chelating AgentsIBA 01/2013 - 07/2002
8	Ferritins (Ferritin)IBA 01/2015 - 01/2003
7	HepcidinsIBA 01/2019 - 08/2010
7	ApoferritinsIBA 01/2017 - 01/2003
7	tachpyrIBA 12/2005 - 06/2003
6	metal transporting protein 1 (ferroportin)IBA 10/2019 - 08/2010
6	Carbon Nanotubes (Carbon Nanotube)IBA 01/2015 - 01/2007
4	Messenger RNA (mRNA)IBA 01/2018 - 08/2010
3	EnzymesIBA 10/2019 - 02/2002
3	Iron Regulatory Protein 2IBA 10/2017 - 01/2014
3	Bone Morphogenetic Proteins (Bone Morphogenetic Protein)IBA 10/2011 - 02/2008
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2020 - 12/2009
2	MetalsIBA 10/2020 - 11/2005
2	Transcription Factors (Transcription Factor)IBA 10/2019 - 11/2004
2	Interleukin-6 (Interleukin 6)IBA 01/2018 - 06/2015
2	Transferrin Receptors (Transferrin Receptor)IBA 01/2017 - 01/2014
2	Phosphotransferases (Kinase)IBA 01/2017 - 11/2005
2	Free RadicalsIBA 01/2016 - 01/2014
2	Phospholipids (Phosphatides)FDA LinkGeneric 01/2015 - 07/2005
2	Oxidants (Oxidizing Agents)IBA 01/2015 - 07/2002
2	Doxycycline (Periostat)FDA LinkGeneric 01/2015 - 12/2008
2	Phenobarbital (Luminal)FDA Link 01/2015 - 01/2014
2	AntioxidantsIBA 06/2011 - 01/2003
2	CurcuminIBA 01/2009 - 04/2006
1	Biological ProductsIBA 10/2020
1	Stearoyl-CoA DesaturaseIBA 10/2019
1	Monounsaturated Fatty AcidsIBA 10/2019
1	LipidsIBA 10/2019
1	Kruppel-Like Factor 6IBA 10/2019
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 10/2019
1	Conditioned Culture MediaIBA 01/2019
1	Peptide Hormones (Polypeptide Hormones)IBA 01/2018
1	antineoplaston A10 (A 10)IBA 01/2018
1	Growth Differentiation Factor 15IBA 01/2018
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2018
1	SulfurIBA 01/2017
1	Heme (Haem)IBA 01/2017
1	MicroRNAs (MicroRNA)IBA 01/2016
1	Hormones (Hormone)IBA 06/2015
1	Small Interfering RNA (siRNA)IBA 05/2015
1	2-nonenalIBA 01/2015
1	SugarsIBA 01/2015
1	Glucosamine (Dona)IBA 01/2015
1	Glucose (Dextrose)FDA LinkGeneric 01/2015
1	Radiation-Sensitizing AgentsIBA 01/2015
1	SilverIBA 01/2015
1	RadiopharmaceuticalsIBA 01/2015
1	Caspase 3 (Caspase-3)IBA 01/2015
1	Vitamin D FDA LinkGeneric 01/2014
1	Cytostatic AgentsIBA 01/2014
1	seocalcitolIBA 01/2014
1	Estrogens (Estrogen)FDA Link 01/2013
1	matrigelIBA 05/2012
1	Tamoxifen FDA LinkGeneric 11/2011
1	SuspensionsIBA 10/2011
1	Bone Morphogenetic Protein 7IBA 10/2011
1	Contrast MediaIBA 10/2011
1	beta CateninIBA 10/2011
1	AntigensIBA 03/2011
1	Lipocalin-2IBA 03/2011
1	Iron-Regulatory Proteins (Iron-Responsive Element Binding Proteins)IBA 03/2011
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 12/2010

Therapy/Procedure

12	Therapeutics 10/2020 - 06/2003
3	Lasers (Laser) 10/2011 - 08/2009
2	Drug Therapy (Chemotherapy) 04/2012 - 01/2004
2	Stem Cell Transplantation 10/2009 - 05/2009
1	Radiotherapy 04/2012
1	Photothermal Therapy 04/2012